Showing results (111-120 of 212) with videos related to

Sort By:
Pageof 22
Hepatic Medicine : Evidence and Research|September 28, 2011
Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitisSumona Ghosh, Meenakshi Kaw, Payal R Patel, et al.
Hepatic Medicine : Evidence and Research|September 20, 2011
Inhibition of Notch signaling affects hepatic oval cell response in rat model of 2AAF-PHHouda Darwiche, Seh-Hoon Oh, Nicole C Steiger-Luther, et al.
Hepatic Medicine : Evidence and Research|July 21, 2025
Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African PopulationJean-Bonny Nsumbu, Jean-Robert Makulo, Trésor Mutombo Tshiswaka, et al.
Hepatic Medicine : Evidence and Research|September 17, 2025
Pharmacological Modulation of Liver and Spleen Stiffness in a Cirrhotic Rat ModelOmar Elshaarawy, Shami Hasan M Alquzi, Felix Piecha, et al.
Hepatic Medicine : Evidence and Research|August 6, 2025
The Effect of Liv.52 DS in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Pilot, Randomized, Double-Blind, Placebo-Controlled, Clinical StudyUmesh Jalihal, Rajesh Amarnath Nanda, Kuldeep Katariya, et al.
Hepatic Medicine : Evidence and Research|August 13, 2014
Ending hepatitis C in the United States: the role of screeningPhillip O Coffin, Andrew Reynolds
Hepatic Medicine : Evidence and Research|September 5, 2014
Systemic vascular resistance in cirrhosis: a predictor of severity?Vinaya Gaduputi, Molham Abdulsamad, Sailaja Sakam, et al.
Hepatic Medicine : Evidence and Research|December 25, 2013
Liver stiffness: a novel parameter for the diagnosis of liver diseaseSebastian Mueller, Laurent Sandrin
Hepatic Medicine : Evidence and Research|December 25, 2013
A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infectionNan Xiao, Shuang Shi, Hui Zhuang
Pageof 22